Skip to main content
Log in

CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects

  • GENETICS
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Polymorphic variants of CYP1A2 and CYP2D6 genes of the cytochrome P450 system were studied in patients with schizophrenia with drug-induced motor disorders and hyperprolactinemia against the background of long-term neuroleptic therapy. We revealed an association of polymorphic variant C-163A CYP1A2*1F of CYP1A2 gene with tardive dyskinesia and association of polymorphic variant 1846G>A CY2D6*4 and genotype A/A of CYP2D6 gene (responsible for debrisoquin-4-hydroxylase synthesis) with limbotruncal tardive dyskinesia in patients with schizophrenia receiving neuroleptics for a long time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. L. N. Gorobets, Neuroendocrine Dysfunctions and Neuroleptic Therapy [in Russian], Moscow (2007).

  2. S. A. Ivanova, O. Yu. Fedorenko, L. P. Smirnova, and A. V. Semke, Sib. Vestn. Psikhiatr. Narkol., No. 1, 12-17 (2013).

  3. V. N. Krasnov, I. Ya. Gurovich, and S. N. Mosolov, Psychiatric Care of Patients with Schizophrenia: Clinical Manual [in Russian], Moscow (2007).

  4. V. G. Kukes, Drug Metabolism: Clinical Pharmacological Aspects [in Russian], Moscow (2004).

  5. A. F. Al Hadithy, S. A. Ivanova, P. Pechlivanoglou, et al., Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, No. 3, 475-481 (2009).

    Article  CAS  PubMed  Google Scholar 

  6. A. F. Al Hadithy, S. A. Ivanova, P. Pechlivanoglou, et al., Hum. Psychopharmacol., 25, No. 1, 84-91 (2010).

    Article  CAS  PubMed  Google Scholar 

  7. A. Ajmal, H. Joffe, and L. B. Nachtigall, Psychosomatics, 55, No. 1, 29-36 (2014).

    Article  PubMed  Google Scholar 

  8. M. J. Arranz, M. Rivera, and J. C. Munro, CNS Drugs, 25, No. 11, 933-969 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. G. Gardos, J. O. Cole, and R. La Brie, Arch. Gen. Psychiatry, 34, No. 10, 1206-1212 (1977).

    Article  CAS  PubMed  Google Scholar 

  10. H. J. Lee and S. G. Kang, Int. Rev. Neurobiol., 98, 231-264 (2011).

    Article  CAS  PubMed  Google Scholar 

  11. A. J. Loonen and S. A. Ivanova, CNS Spectr., 18, No. 1, 15-20 (2013).

    Article  PubMed  Google Scholar 

  12. W. Maier and A. Zobel, Eur. Arch. Psychiatry Clin. Neurosci., 258, Suppl. 1, 12-20 (2008).

  13. G. P. Reynolds, Drug Discov. Today, 12, No. 21-22, 953-959 (2007).

    Article  CAS  PubMed  Google Scholar 

  14. M. A. Rothsten, Pharmacogenomics, New Jersey (2003).

  15. R. Tandon, M. S. Keshavan, and H. A. Nasrallah, Schizophr. Res., 100, Nos. 1-3, 4-19 (2008).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. A. Ivanova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 160, No. 11, pp. 639-643, November, 2015

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ivanova, S.A., Filipenko, M.L., Vyalova, N.M. et al. CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects. Bull Exp Biol Med 160, 687–690 (2016). https://doi.org/10.1007/s10517-016-3250-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-016-3250-4

Key Words

Navigation